<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90667">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845753</url>
  </required_header>
  <id_info>
    <org_study_id>MS-LS-DK-02</org_study_id>
    <nct_id>NCT01845753</nct_id>
  </id_info>
  <brief_title>Molecular Screening for Lynch Syndrome in Denmark</brief_title>
  <official_title>Molecular Screening for Lynch Syndrome in Denmark</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vejle Hospital</source>
  <oversight_info>
    <authority>Denmark: The National Board of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinically applicably strategy for molecular screening for Lynch Syndrome is being
      implemented in Denmark.

      Based on sequential analysis with immunohistochemistry and methylation analysis, patients
      with possible hereditary colorectal cancer are identified. These patients are offered
      genetic risk assessment and counselling.

      The study hypothesis is that molecular screening will identify more patients with Lynch
      Syndrome than the family history alone.

      Prospective data collection is performed using established clinical databases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Rate of Lynch Syndrome in a population of primary colorectal cancer</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Lynch Syndrome</condition>
  <condition>HNPCC</condition>
  <arm_group>
    <arm_group_label>All colorectal cancer patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Observation</description>
    <arm_group_label>All colorectal cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All colorectal cancer patients in Denmark
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological diagnosis of colorectal adenocarcinoma

          -  Diagnosed at one of the departments of pathology in Denmark

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lars Henrik Jensen, MD PhD</last_name>
    <phone>+4579406802</phone>
    <email>lars.henrik.jensen@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mogens Vyberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Clinical Genetics</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Bine Skytte</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torben Steiniche</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Esbjerg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrine U Hansen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Hjoerring</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars J Joergensen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Clinical Genetics</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilian B Ousager</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tine Plato</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>SÃ¸nderborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Ladefoged</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Henrik Jensen, MD PhD</last_name>
      <email>lars.henrik.jensen@rsyd.dk</email>
    </contact>
    <investigator>
      <last_name>Lars Henrik Jensen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Clinical Genetics</name>
      <address>
        <city>Vejle</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Bojesen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathology</name>
      <address>
        <city>Vejle</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Lindebjerg</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 28, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms, Hereditary Nonpolyposis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
